Mounjaro 5mg Injection Pen

Description

Mounjaro 5mg injection pen (tirzepatide) is a breakthrough once-weekly injectable medication that acts on both GLP-1 and GIP receptors, enhancing your body’s natural insulin response while helping control appetite and promote steady weight reduction.

This 5mg pen is typically the second step in the Mounjaro dosage plan (following 2.5mg) and is ideal for those already tolerating initial therapy and ready for more pronounced results.

Key Features:

• Dual incretin therapy: GLP-1 + GIP receptor agonist

• Contains 5mg tirzepatide per injection

• Supports blood sugar stabilization and weight loss

• Once-weekly dosing

• Clinically proven efficacy (FDA Overview)

Usage Instructions:

• Inject once weekly, on the same day each week

• Can be administered in the abdomen, thigh, or upper arm

• Rotate injection sites with each dose

• Begin only after completing the 2.5mg introduction dose, under medical supervision

Mounjaro 5mg Injection Pen Side Effects:

Possible side effects include mild nausea, fatigue, or digestive changes that usually lessen with continued use. For complete medical guidance, consult your healthcare provider or review the Mounjaro Medication Guide.

Storage Instructions:

• Store in a refrigerator between 36°F–46°F (2°C–8°C)

• Do not freeze

• Keep the pen in its original carton to protect from light